Itacitinib Monotherapy for Low-Risk Acute GVHD
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Blood
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effective treatment of low risk acute GVHD with itacitinib monotherapy
Blood 2022 Sep 12;[EPub Ahead of Print], AM Etra, A Capellini, AM Alousi, MM Al Malki, HK Choe, Z DeFilipp, WJ Hogan, CL Kitko, FA Ayuk, J Baez, I Gandhi, S Kasikis, S Gleich, E Hexner, M Hoepting, U Kapoor, S Kowalyk, D Kwon, A Langston, M Mielcarek, G Morales, U Özbek, M Qayed, R Reshef, W Roesler, N Spyrou, R Young, YB Chen, JL Ferrara, JE LevineFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.